A leader in the world of cellular therapies.

Cook MyoSite® is a leader in the regenerative medicine industry by advancing our own personalized investigational cell therapy products toward the market through extensive clinical trial experience.

 

 

x
Newsroom

FDA Grants RMAT Designation to Cook MyoSite's AMDC-USR

Dec. 17, 2020 — Cook MyoSite today announced that the FDA has granted the Regenerative Medicine Advanced Therapy (RMAT) designation to Cook MyoSite’s AMDC-USR investigational product for treatment of women with persistent or recurrent stress urinary incontinence (SUI) following surgical treatment.

READ MORE >

OUR MISSION

Cook MyoSite’s mission is to make regenerative medicine a part of everyday medicine.

 

 

LEARN MORE >

CLINICAL APPLICATIONS

Cook MyoSite creates specialized treatments for patients. These treatments use the patient’s own muscle cells in a unique procedure that begins and ends with the patient’s own body. Currently, this technology is being investigated in clinical trials and is not commercially available.

 

CLINICAL APPLICATIONS >